Literature DB >> 2150922

Ligand thresholds at different stages of T cell development.

J Yagi1, C A Janeway.   

Abstract

Certain T cell ligands can stimulate most or all T cells whose receptor is encoded by particular V beta genes. Exposure to these same ligands during intrathymic development leads to deletion of T cells bearing these same receptors. We have utilized one such ligand, staphylococcal enterotoxin B (SEB), to examine the quantitative differences in these two responses. By comparing the dose of SEB required to delete developing T cells in thymic organ culture with that required to stimulate spleen cells to expand clonally, we observe that clonal deletion is one to two orders of magnitude more sensitive to SEB. Because the T cell ligand involves not only SEB but also class II MHC molecules, and because the culture conditions are distinct, this system does not allow one to state that intrathymic T cells are intrinsically more sensitive to negative selection than peripheral T cells are to activation. However, these studies for the first time do establish a quantitative comparison of these two processes and suggest that there is a margin for error built into the clonal deletion process, such that ligands presented in the thymus are 30- to 100-fold more active in clonal deletion than is the same ligand in activation of peripheral T cells. This result agrees well with the observation that naturally occurring unknown ligands associated with I-E can clonally delete cells that are not activated by the same ligand in mixed lymphocyte culture.

Mesh:

Substances:

Year:  1990        PMID: 2150922     DOI: 10.1093/intimm/2.1.83

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  17 in total

Review 1.  Function and regulation of memory CD4 T cells.

Authors:  D P Metz; K Bottomly
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.

Authors:  Christophe Viret; Xin He; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

3.  Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.

Authors:  A Brooks; S Hartley; L Kjer-Nielsen; J Perera; C C Goodnow; A Basten; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain.

Authors:  M Noguchi; A Sarin; M J Aman; H Nakajima; E W Shores; P A Henkart; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 5.  Indoctrinating T cells to attack pathogens through homeschooling.

Authors:  Caitlin S Parello; Eric S Huseby
Journal:  Trends Immunol       Date:  2015-05-12       Impact factor: 16.687

6.  Paradoxical intrathymic positive selection in mice with only a covalently presented agonist peptide.

Authors:  C Viret; X He; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

7.  Negative selection of thymocytes expressing the D10 TCR.

Authors:  Derek B Sant'Angelo; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction.

Authors:  Danielle F Atibalentja; Craig A Byersdorfer; Emil R Unanue
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Negative selection imparts peptide specificity to the mature T cell repertoire.

Authors:  Eric S Huseby; Frances Crawford; Janice White; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

10.  Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression.

Authors:  Lance M Relland; Manoj K Mishra; Dipica Haribhai; Brandon Edwards; Jennifer Ziegelbauer; Calvin B Williams
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.